The Viral CC Chemokine-binding Protein vCCI Inhibits Monocyte Chemoattractant Protein-1 Activity by Masking Its CCR2B-binding Site*

Monocyte chemoattractant protein-1 (MCP-1) is a chemotactic cytokine mainly acting on monocytes and T cells that elicits its biological effects by interacting with the seven-transmembrane helix receptor CCR2B. The vaccinia virus strain Lister and many other poxviruses express soluble proteins (vCCI) that bind MCP-1 and other CC chemokines and inhibit their function. In order to define the interaction site of MCP-1 with vCCI from vaccinia, surface exposed residues of MCP-1 were identified and mutated to alanine. The MCP-1 variants were expressed, purified, and their interaction with vCCI was characterized. The site on MCP-1 for vCCI binding is dominated by arginine 18 with important additional contributions from tyrosine 13 and arginine 24. These residues define a binding site that largely overlaps with the CCR2B receptor interaction site. The viral chemokine-binding protein vCCI thus inhibits the biological function of MCP-1 by directly masking its CCR2B receptor-binding site.

[1]  Charles Eigenbrot,et al.  Crystal Structure at 1.7 Å Resolution of VEGF in Complex with Domain 2 of the Flt-1 Receptor , 1997, Cell.

[2]  G. McFadden,et al.  Functional comparisons among members of the poxvirus T1/35kDa family of soluble CC-chemokine inhibitor glycoproteins. , 1998, Virology.

[3]  N. Stow,et al.  DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister. , 1990, The Journal of general virology.

[4]  M. Gerhart,et al.  Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits beta chemokine activity yet lacks sequence homology to known chemokine receptors. , 1997, Virology.

[5]  R. Moyer,et al.  Mapping and investigation of the role in pathogenesis of the major unique secreted 35-kDa protein of rabbitpox virus. , 1995, Virology.

[6]  J J Goedert,et al.  Contrasting genetic influence of CCR2 and CCR5 variants on HIV-1 infection and disease progression. Hemophilia Growth and Development Study (HGDS), Multicenter AIDS Cohort Study (MACS), Multicenter Hemophilia Cohort Study (MHCS), San Francisco City Cohort (SFCC), ALIVE Study. , 1997, Science.

[7]  G. McFadden,et al.  Secreted poxvirus chemokine binding proteins , 1997, Journal of leukocyte biology.

[8]  J. Wells,et al.  Systematic mutational analyses of protein-protein interfaces. , 1991, Methods in enzymology.

[9]  C. Mackay,et al.  Chemokines: immunology's high impact factors , 2001, Nature Immunology.

[10]  E. Lazarides,et al.  Mapping of MCP‐1 functional domains by peptide analysis and site‐directed mutagenesis , 1998, FEBS letters.

[11]  C. Smith,et al.  Cowpox virus contains two copies of an early gene encoding a soluble secreted form of the type II TNF receptor. , 1994, Virology.

[12]  C. J. Beall,et al.  Site-directed mutagenesis of monocyte chemoattractant protein-1 identifies two regions of the polypeptide essential for biological activity. , 1996, The Biochemical journal.

[13]  K. Matsushima,et al.  Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line , 2022 .

[14]  A. Zlotnik,et al.  Chemokines: a new classification system and their role in immunity. , 2000, Immunity.

[15]  T. Clackson,et al.  A hot spot of binding energy in a hormone-receptor interface , 1995, Science.

[16]  P. Domaille,et al.  Heteronuclear (1H, 13C, 15N) NMR assignments and solution structure of the monocyte chemoattractant protein-1 (MCP-1) dimer. , 1996, Biochemistry.

[17]  B. Rollins,et al.  Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. , 1994, The Journal of biological chemistry.

[18]  J. Wells,et al.  High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. , 1989, Science.

[19]  D. Liggitt,et al.  Local Blockade of Allergic Airway Hyperreactivity and Inflammation by the Poxvirus-Derived Pan-CC-Chemokine Inhibitor vCCI1 , 2000, The Journal of Immunology.

[20]  P. Rabinovitch,et al.  Improved sensitivity in flow cytometric intracellular ionized calcium measurement using fluo-3/Fura Red fluorescence ratios. , 1994, Cytometry.

[21]  ANTAGONISTS OF MONOCYTE CHEMOATTRACTANT PROTEIN 1 IDENTIFIED BY MODIFICATION OF FUNCTIONALLY CRITICAL NH2-TERMINAL RESIDUES , 1995 .

[22]  L. Presta,et al.  Mapping the Charged Residues in the Second Immunoglobulin-like Domain of the Vascular Endothelial Growth Factor/Placenta Growth Factor Receptor Flt-1 Required for Binding and Structural Stability* , 1998, The Journal of Biological Chemistry.

[23]  L. Rogers,et al.  Lysine 58 and Histidine 66 at the C-terminal α-Helix of Monocyte Chemoattractant Protein-1 Are Essential for Glycosaminoglycan Binding* , 1998, The Journal of Biological Chemistry.

[24]  G. McFadden,et al.  The T1/35kDa family of poxvirus-secreted proteins bind chemokines and modulate leukocyte influx into virus-infected tissues. , 1997, Virology.

[25]  P. Murphy.  Viral exploitation and subversion of the immune system through chemokine mimicry , 2001, Nature Immunology.

[26]  L. Presta,et al.  The binding epitopes of neurotrophin‐3 to its receptors trkC and gp75 and the design of a multifunctional human neurotrophin. , 1994, The EMBO journal.

[27]  D. Wiley,et al.  Structure of a soluble secreted chemokine inhibitor vCCI (p35) from cowpox virus. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Alcamí,et al.  Blockade of chemokine activity by a soluble chemokine binding protein from vaccinia virus. , 1998, Journal of immunology.

[29]  A. Kerlavage,et al.  Potential virulence determinants in terminal regions of variola smallpox virus genome , 1993, Nature.

[30]  K. Jarnagin,et al.  Monomeric Monocyte Chemoattractant Protein-1 (MCP-1) Binds and Activates the MCP-1 Receptor CCR2B* , 1998, The Journal of Biological Chemistry.

[31]  W. Delano,et al.  Convergent solutions to binding at a protein-protein interface. , 2000, Science.

[32]  G. McFadden,et al.  The purified myxoma virus gamma interferon receptor homolog M-T7 interacts with the heparin-binding domains of chemokines , 1997, Journal of virology.

[33]  M. Ultsch,et al.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. , 1992, Science.

[34]  K. Jarnagin,et al.  Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. , 1999, Biochemistry.

[35]  J. Kuratsu,et al.  Purification and amino acid analysis of two human glioma-derived monocyte chemoattractants , 1989, The Journal of experimental medicine.

[36]  Christian Wiesmann,et al.  Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor , 1999, Nature.